ArticleRadiology. Imaging cancer2026
Assessing an Automated Noncontrast CT-based Pipeline for Sacral Tumor Classification Using a Hip Bone Reference Frame.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anchoring Pelvic AI: A Hip Bone Reference Frame for Sacral Tumor Classification in Noncontrast CT.Radiology. Imaging cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop a fully automated hybrid approach to predict sacral tumor types from preoperative noncontrast CT (NCCT ) images. Materials and Methods In this retrospective, multicenter study, scans were available in 690 patients who had histopathologically confirmed preoperative sacral NCCT performed between January 2011 and May 2024. A fully automated hybrid model integrated two deep convolutional neural network models (model 1 and model 2) through a fully automated pipeline. Model 1 segments tumors and hip bones automatically from NCCT images, producing masks that are used by model 2. For the first time, the hip bone was used as a reference frame for tumor localization. The second model, CL-MedImageNet, is an innovative six-classification model that allows the simultaneous input of tumor images, clinical data, and location information. This streamlined, automated system ensures efficient data integration and processing between the two models. The efficacy of the model was assessed in comparison to that of radiologists, using metrics including the area under the curve (AUC), F1 score, and confusion matrix. Results In all, 690 patients (mean age, 46 years ± 17 [SD]; 377 male patients) were included. Segmentation achieved mean Dice coefficients of 0.82 ± 0.11 (validation), 0.81 ± 0.12 (internal test), and 0.81 ± 0.12 (external test) after postprocessing; interobserver Dice coefficient was 0.96. The CL-MedImageNet classifier attained macro average AUCs of 0.89 (95% CI: 0.83, 0.93), 0.88 (95% CI: 0.84, 0.92), and 0.87 (95% CI: 0.79, 0.92) in validation, internal, and external test sets, respectively, with macro average F1 scores of 0.63, 0.63, and 0.56. The highest achieved precision and sensitivity were both 0.66 across all sets. CL-MedImageNet outperformed radiologists (macro average AUCs, 0.87 vs 0.80,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.